Investigating genetic variations within a primary tumor, the differences between the primary tumor and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the bloodstream could help guide and improve treatment choices in patients with gastroesophageal adenocarcinoma (GEA), according to a recent study.

Read More

News

By David Douglas

NEW YORK (Reuters Health) - Analysis of multiple data sets has helped to elucidate how four recently revealed molecular subsets of gastric cancer might best be managed, according to researchers in the United States and Korea.

Read More

A team of investigators has developed a scoring system that may inform decision-making for the treatment of gastrointestinal neuroendocrine carcinomas.

Read More

Subscribe to Gastrointestinal Cancer